Overview

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Rizatriptan, a migraine medication, lowers motion sickness in migraine sufferers.
Phase:
N/A
Details
Lead Sponsor:
University of Pittsburgh
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Rizatriptan